Komori
Earnings7071Amvis Holdings,Inc.Information and Communications, Services and Others

Summary of Financial Results for the Third Quarter of the Fiscal Year Ending September 2026 (Japanese GAAP, Consolidated)

Nine-month revenue increased 5.3% year on year, while operating income declined 22.9% and ordinary income declined 23.9%. Although revenue grew, profits fell due to upfront staffing for the opening of new facilities and higher personnel expenses.

Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
1074
million yen (decrease in operating profit)
Wording
Conditional
How definitive the wording is.

Results for this period

Third quarter1 October 2025 to 30 June 2026ConsolidatedJapanese GAAP
Net Sales38,288¥ millionYear on year +5.3%Progress 74.1%
Operating profit3,623¥ millionYear on year -22.9%Progress 95.3%
Ordinary income3,681¥ millionYear on year -23.9%Progress 111.5%
Net income attributable to owners of the parent2,485¥ millionYear on year -17.1%Progress 118.3%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥25.41
Financial position at period-end
Total assets78,555¥ million
of which net assets 38,555 ¥ millionEquity ratio 49.0%vs. prior year-end +6.0pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Segment revenueIshinkan medical care residences ¥37,393 million (YoY +3.9%), Comprehensive Medical Support ¥897 million (YoY +131.1%)
Segment profitIshinkan medical care residences ¥3,023 million (YoY -33.8%), Comprehensive Medical Support ¥599 million (YoY +356.4%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥51,700 million (YoY +5.1%)
Operating profit¥3,800 million (YoY -38.3%)
Ordinary income¥3,300 million (YoY -48.0%)
Net income¥2,100 million (YoY -42.6%)
Revision to Earnings ForecastNo
Annual Dividend Forecast¥4 → ¥4(0.0%)
Factors Behind Changes in Business Performance

At Ishinkan, the factors were a temporary decline in facility utilization due to the response to the special investigation committee and related matters, the ramp-up in operations at facilities opened in the previous fiscal year, and upfront staffing and higher personnel expenses associated with opening new facilities. In Comprehensive Medical Support, the factors were an increase of 2 supported medical institutions and the expansion of services provided to existing supported institutions.

Disclosure regarding the going concern assumption

Not applicable.

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 companies (company name: —) / Excluded 0 companies (company name: —)
Breakdown of extraordinary income (loss)Extraordinary income Gain on business transfer ¥34 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥14 million
Depreciation and amortization¥2,425 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End98,112,000 Shares
Treasury Shares at Period-End58,857 Shares
Results for this period
ItemDetails
Fiscal Period ClassificationThird quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 October 2025 to 30 June 2026
Net Sales¥38,288 million (YoY +5.3%)
Operating profit¥3,623 million (YoY -22.9%)
Ordinary income¥3,681 million (YoY -23.9%)
Profit attributable to owners of the parent¥2,485 million (YoY -17.1%)
Net income per share¥25.41
Equity ratioEnd of the current fiscal period 49 / End of previous period 43
Total assets¥78,555 million
Net assets¥38,555 million
Full-year earnings forecastNet Sales ¥51,700 million (YoY +5.1%) / Operating profit ¥3,800 million (YoY -38.3%) / Ordinary income ¥3,300 million (YoY -48.0%) / Net income ¥2,100 million (YoY -42.6%)
Revision to Earnings ForecastNo
Annual Dividend Forecast¥4 → ¥4(0.0%)
Segment revenueIshinkan medical care residences ¥37,393 million (YoY +3.9%), Comprehensive Medical Support ¥897 million (YoY +131.1%)
Segment profitIshinkan medical care residences ¥3,023 million (YoY -33.8%), Comprehensive Medical Support ¥599 million (YoY +356.4%)
Depreciation and amortization¥2,425 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on business transfer ¥34 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥14 million
Disclosure regarding the going concern assumptionNot applicable.
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew 0 companies (company name: —) / Excluded 0 companies (company name: —)
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End98,112,000 Shares
Treasury Shares at Period-End58,857 Shares
Factors Behind Changes in Business PerformanceAt Ishinkan, the factors were a temporary decline in facility utilization due to the response to the special investigation committee and related matters, the ramp-up in operations at facilities opened in the previous fiscal year, and upfront staffing and higher personnel expenses associated with opening new facilities. In Comprehensive Medical Support, the factors were an increase of 2 supported medical institutions and the expansion of services provided to existing supported institutions.
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogImpairment lossMaterial subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

At Ishinkan, facility utilization temporarily declined due to the response to the special investigation committee and related matters, while revenue increased as facilities opened in the previous fiscal year ramped up operations. Gross profit margin declined and segment profit decreased due to upfront staffing for the opening of new facilities and higher personnel expenses to secure personnel. Comprehensive Medical Support posted higher revenue and profit due to an increase in the number of supported medical institutions and the expansion of services provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Third Quarter of the Fiscal Year Ending September 2026 (Japanese GAAP, Consolidated) | Amvis Holdings,Inc. (7071) timely disclosure | Komori